|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile |
International Nonproprietary Names ![]() |
|
INN number | INN |
9818 | osilodrostat |
Synonyms ![]() |
LCI-699 | LCI699 |
Database Links ![]() |
|
CAS Registry No. | 928134-65-0 |
ChEMBL Ligand | CHEMBL3099695 |
GtoPdb PubChem SID | 252166522 |
PubChem CID | 44139752 |
Search Google for chemical match using the InChIKey | USUZGMWDZDXMDG-CYBMUJFWSA-N |
Search Google for chemicals with the same backbone | USUZGMWDZDXMDG |
Search PubMed clinical trials | osilodrostat |
Search PubMed titles | osilodrostat |
Search PubMed titles/abstracts | osilodrostat |
Search UniChem for chemical match using the InChIKey | USUZGMWDZDXMDG-CYBMUJFWSA-N |
Search UniChem for chemicals with the same backbone | USUZGMWDZDXMDG |
Comments |
Osilodrostat was designed as an inhibitor of aldosterone synthase (CYP11B2), but is also reported to inhibit the closely related enzyme, 11-beta-hydroxylase (CYP11B1) [7]. |